
|Articles|April 26, 2013
Clinical Global Impressions scale - CGI
Advertisement
The
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation
2
Targeting APOE4: A Promising Therapeutic Strategy for Alzheimer Disease
3
Future DSM Plans Overlook Core Problem of Validity
4
Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia
5







